1.
Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media. Braz. J. Pharm. Sci. [Internet]. 2020 Dec. 9 [cited 2024 Apr. 29];56:e18583. Available from: https://www.revistas.usp.br/bjps/article/view/181913